Thrombin Mutant W215A/E217A Treatment Improves Neurological Outcome and Reduces Cerebral Infarct Size in a Mouse Model of Ischemic Stroke - Concepedia

Concepedia

Publication | Open Access

Thrombin Mutant W215A/E217A Treatment Improves Neurological Outcome and Reduces Cerebral Infarct Size in a Mouse Model of Ischemic Stroke

DOI Full Paper Access

28

Citations

26

References

2011

Year

Michelle A. Berny‐Lang, Sawan Hurst, Erik I. Tucker, Leslie A. Pelc, Ruikang K. Wang, Patricia D. Hurn, Enrico Di, Owen J. T. McCarty, András Gruber

Abstract

WE treatment is neuroprotective without hemostasis impairment in experimental acute ischemic stroke in mice and thus may provide an alternative to tissue plasminogen activator for stroke treatment.

References

	Year	Citations

Page 1